Liqun Gu

Title: Innovations of Liqun Gu in Cancer Research

Introduction

Liqun Gu is a prominent inventor based in Plainsboro, MA (US), known for his significant contributions to cancer research. He holds 2 patents that focus on lymphoma-associated molecules and their applications in diagnostics and therapeutics.

Latest Patents

One of his latest patents is titled "Lymphoma associated molecules and uses therefor." This invention provides isolated nucleic acid molecules, designated BBAP nucleic acid molecules, which encode proteins that interact with or bind to BAL molecules, differentially expressed in non-Hodgkin's lymphoma. The invention also includes antisense nucleic acid molecules, recombinant expression vectors containing BBAP nucleic acid molecules, and host cells into which these expression vectors have been introduced. Additionally, it encompasses non-human transgenic animals in which a BBAP gene has been introduced or disrupted. The invention further provides isolated BBAP proteins, fusion proteins, antigenic peptides, and anti-BBAP antibodies. Diagnostic methods utilizing the compositions of this invention are also included.

Career Highlights

Liqun Gu is affiliated with the Dana-Farber Cancer Institute Inc., where he continues to advance research in the field of oncology. His work has been instrumental in understanding the molecular mechanisms underlying lymphoma, paving the way for potential therapeutic interventions.

Collaborations

Some of his notable coworkers include Margaret A. Shipp and Ricardo Aguiar, who have collaborated with him on various research projects aimed at improving cancer treatment strategies.

Conclusion

Liqun Gu's innovative work in the field of cancer research, particularly in the development of lymphoma-associated molecules, showcases his commitment to advancing medical science. His contributions are vital for the ongoing fight against cancer and highlight the importance of research in developing effective diagnostic and therapeutic tools.